Brooklyn Investment Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,381
Closed -$1.36M 1906
2025
Q4
$1.36M Buy
+13,381
New +$1.07M 0.06% 254
2025
Q3
Sell
-139
Closed -$7.39K 1327
2025
Q2
$7.39K Buy
139
+20
+17% +$1.02K ﹤0.01% 2313
2025
Q1
$5.15K Sell
119
-56
-32% -$2.84K ﹤0.01% 1808
2024
Q4
$9.83K Buy
175
+76
+77% +$4.73K ﹤0.01% 986
2024
Q3
$6.74K Buy
+99
New +$5.59K ﹤0.01% 833

Other funds holding EXAS

Brooklyn Investment Group's EXAS Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,381 shares — an estimated $1.36M sold.

Brooklyn Investment Group first reported a position in EXAS in Q3 2024 and held it in 5 quarters. The position peaked at $1.36M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 13,381 Exact Sciences shares in Q1 2026, an estimated $1.36M.
  • Brooklyn Investment Group first reported a position in Exact Sciences in Q3 2024 and held it in 5 quarters.
  • Brooklyn Investment Group's Exact Sciences position peaked at $1.36M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.